Home > Chemicals & Materials > Surfactants > Biodegradable Surfactants > Biosurfactants Market
Biosurfactant Market size was valued over USD 8 billion in 2022 and is set to depict around 5% CAGR from 2023 to 2032. The growing demand for biosurfactants in various applications including soaps & detergents, personal care, and industrial cleaning is expected to drive the industry growth.
Rising awareness among consumers about eco-friendly alternatives in personal care and cosmetic products will boost the industry demand over the forecast timeframe. The industry is booming due to environmentally friendly, non-toxic, and biodegradability properties, creating an advantage over synthetic surfactants, thus encouraging surfactant manufacturers to manufacture biosurfactants.
High per-capita spending capacity and consumer preferences toward bio-based ingredients in the final product formulations will drive the global industry growth. Biosurfactants, also known as microbial surfactants, usually involve high manufacturing costs that may act as a growth restraining factor. Nevertheless, the broad application spectrum, the increased cognizance of the product benefits, and the inception of favorable government initiatives are likely to strengthen the biosurfactants market outlook over the next ten years.
Report Attribute | Details |
---|---|
Base Year: | 2022 |
Biosurfactants Market Size in 2022: | USD 8.45 billion |
Forecast Period: | 2023 to 2032 |
Forecast Period 2023 to 2032 CAGR: | 5% |
2032 Value Projection: | USD 14.3 billion |
Historical Data for: | 2018 to 2022 |
No. of Pages: | 795 |
Tables, Charts & Figures: | 1,295 |
Segments covered: | Product |
Growth Drivers: |
|
Pitfalls & Challenges: |
|
The rhamnolipids biosurfactants market is poised to be worth over USD 3 billion by 2032. Rhamnolipids are extensively utilized across the pharmaceutical and therapeutics industries owing to their low toxicity and capability to inhibit the growth of several human cancer cell lines. Moreover, the expanding product applications in personal care products due to its increased solubility and good foaming & wetting tendencies have led to of the use of rhamnolipids in cosmetic industry.
Rhamnolipids are used in healthcare products in different formulations including antacids, acne pads, anti-dandruff products, and contact lens solution. Rhamnolipids are effective in wound healing, treatments, preventing gum diseases, and averting antimicrobial & antiviral activities. These factors are anticipated to drive the rhamnolipids demand in pharmaceutical applications and subsequently stimulate market expansion.
The sophorolipids biosurfactants market from personal care application segment was worth over USD 720 million in 2022 and is expected to witness around 7.5% CAGR through 2032. Sophorolipids are widely used as foaming agents, emulsifiers, wetting agents, solubilizers, and active ingredients in several cosmetic formulations. The tremendous uptick in demand for personal care and cosmetic products driven by the increasing expenditure on beauty and aesthetics will bring about lucrative gains to the bio based surfactants industry.
North America biosurfactants market from mannosylerythritol products is projected to amass more than USD 1 billion by 2032. Mannosylerythritol Lipids (MEL) have antimicrobial properties, hence are used for manufacturing face masks, face wash, and other skin care products. The regional growth can be credited to the rising disposable incomes and the increasing sales of cosmetics and personal care products. Besides, the growing awareness about mental health coupled with the proven effectiveness of mannosylerythritol lipids in treating schizophrenia and other diseases caused by microbial infections and dopamine metabolic dysfunction will fuel the regional industry landscape. Asia Pacific Biosurfactants industry is estimated to grow at over 5.5% CAGR in the coming years owing to widening applications and ecofriendly aspects.
Major companies operating in the biosurfactants market include:
Players in the competitive landscape have been emphasizing expanding their production capabilities to gain access to a broader customer base and make the most of available growth opportunities. For instance, in January 2022, Evonik announced its plan to construct a new industrial-scale facility to boost rhamnolipid biosurfactants production at its Slovakia site. The construction of the new establishment is expected to be accomplished by the end of 2023.
The COVID-19 crisis had a positive influence on the global market. Biosurfactants are used in a range of industrial and medical applications and their innate versatility opened up new avenues for their utilization in several COVID-related applications. Personal and home care products such as disinfectants, handwashes, and cleaning supplies witnessed a massive surge in sales owing to their effectiveness in mitigating viral transmission. Pharmaceuticals and healthcare industries also observed a significant boom, which, in combination with the increasing drug development projects, transformed the market dynamics.
Nonetheless, the growing severity of the crisis and the accelerating pace of hospital admissions inflated the demand for advanced drug delivery systems, creating positive prospects for the biosurfactants industry.
Click here to Buy Section of this Report
By Product
The above information is provided on a country basis for the following: